Short pages

Showing below up to 500 results in range #1 to #500.

1. (hist) ‎Heat Stroke ‎[0 bytes]
2. (hist) ‎Hospital Acquired Infections ‎[0 bytes]
3. (hist) ‎Proptosis/exophthalmos ‎[0 bytes]
4. (hist) ‎Hypoxaluria ‎[0 bytes]
5. (hist) ‎Be bold in updating pages ‎[0 bytes]
6. (hist) ‎Impingement Syndrome ‎[0 bytes]
7. (hist) ‎Carteolol (patient information) ‎[0 bytes]
8. (hist) ‎Ddx:Amnesia ‎[0 bytes]
9. (hist) ‎Stent thrombosis: Definition ‎[0 bytes]
10. (hist) ‎Streptobacillus moniliformis infection ‎[0 bytes]
11. (hist) ‎Modified Gervino Protocol ‎[0 bytes]
12. (hist) ‎Embryonal carcinoma ‎[0 bytes]
13. (hist) ‎Cytomegalovirus retinitis ‎[0 bytes]
14. (hist) ‎Sapan Desai ‎[0 bytes]
15. (hist) ‎Acamprosate ‎[0 bytes]
16. (hist) ‎Enalapril and Felodipine ‎[0 bytes]
17. (hist) ‎Enalapril and Hydrochlorothiazide ‎[0 bytes]
18. (hist) ‎Levodopa and Carbidopa ‎[0 bytes]
19. (hist) ‎Oxycodone and aspirin ‎[0 bytes]
20. (hist) ‎8-Hydroxyquinoline ‎[0 bytes]
21. (hist) ‎Chlamydia (bacterium) ‎[0 bytes]
22. (hist) ‎Autograft ‎[0 bytes]
23. (hist) ‎Bilateral ‎[0 bytes]
24. (hist) ‎Tributaries ‎[0 bytes]
25. (hist) ‎Superficial iliac circumflex ‎[0 bytes]
26. (hist) ‎Superficial external pudendal ‎[0 bytes]
27. (hist) ‎(pyruvate dehydrogenase (acetyl-transferring))-phosphatase ‎[0 bytes]
28. (hist) ‎Vegetable oil ‎[0 bytes]
29. (hist) ‎Analytical chemistry ‎[0 bytes]
30. (hist) ‎Sexual activity ‎[0 bytes]
31. (hist) ‎Feer's disease ‎[0 bytes]
32. (hist) ‎Inflammatory Bowel Syndrome ‎[0 bytes]
33. (hist) ‎Air ‎[0 bytes]
34. (hist) ‎Membranoproliferative GN ‎[0 bytes]
35. (hist) ‎Physical properties ‎[0 bytes]
36. (hist) ‎Carbon-nitrogen cycle ‎[0 bytes]
37. (hist) ‎Peer-reviewed ‎[0 bytes]
38. (hist) ‎Working area ‎[0 bytes]
39. (hist) ‎Platyhelminthes ‎[0 bytes]
40. (hist) ‎Perforation ‎[0 bytes]
41. (hist) ‎Carl Scherzer ‎[0 bytes]
42. (hist) ‎IUPAC nomenclature of inorganic chemistry ‎[0 bytes]
43. (hist) ‎Right upper quadrant (abdomen) ‎[0 bytes]
44. (hist) ‎Unstable Angina / Non ST Elevation Myocardial Infarction:Bleeding / Transfusion and Complications of Bleeding with NSTEMI ‎[0 bytes]
45. (hist) ‎Bose-Einstein condensation ‎[0 bytes]
46. (hist) ‎Pseudothrombocytopenia ‎[0 bytes]
47. (hist) ‎Hazchem ‎[0 bytes]
48. (hist) ‎Self-talk ‎[0 bytes]
49. (hist) ‎Feelings ‎[0 bytes]
50. (hist) ‎Ventricular Tachycardia Including Torsades De Pointes and Polymorphic Ventricular Tachycardia ‎[0 bytes]
51. (hist) ‎Labyrinth ‎[0 bytes]
52. (hist) ‎Expectorate ‎[0 bytes]
53. (hist) ‎Glossary of climbing terms ‎[0 bytes]
54. (hist) ‎US Standard Atmosphere ‎[0 bytes]
55. (hist) ‎Lump ‎[0 bytes]
56. (hist) ‎Isoprotenerol ‎[0 bytes]
57. (hist) ‎Polyoxide ‎[0 bytes]
58. (hist) ‎Strain (materials science) ‎[0 bytes]
59. (hist) ‎HIV/AIDS in Myanmar ‎[0 bytes]
60. (hist) ‎Scientific reductionism ‎[0 bytes]
61. (hist) ‎Impacted ‎[0 bytes]
62. (hist) ‎Beamline ‎[0 bytes]
63. (hist) ‎FDA label ‎[0 bytes]
64. (hist) ‎Mph ‎[0 bytes]
65. (hist) ‎Antepartum and postpartum bleeding ‎[0 bytes]
66. (hist) ‎Chronic Stable Angina Rehabilitation ‎[0 bytes]
67. (hist) ‎Unstable angina / non ST elevation myocardial infarction diagnosis ‎[0 bytes]
68. (hist) ‎Synophrys ‎[0 bytes]
69. (hist) ‎Notch ‎[0 bytes]
70. (hist) ‎Schiff reagent ‎[0 bytes]
71. (hist) ‎Unstable angina risk stratification and prognosis ‎[0 bytes]
72. (hist) ‎Effect Of Continuous Positive Airway Pressure And Noninvasive Positive Pressure Ventilation In Acute Cardiogenic Pulmonary Oedema ‎[0 bytes]
73. (hist) ‎Index.php ‎[0 bytes]
74. (hist) ‎CARVEDILOL ‎[0 bytes]
75. (hist) ‎Salivary gland (patient information) ‎[0 bytes]
76. (hist) ‎Stent thrombosis: Introduction ‎[0 bytes]
77. (hist) ‎Prevention of coronary stent thrombosis ‎[0 bytes]
78. (hist) ‎Prognosis of coronary stent thrombosis ‎[0 bytes]
79. (hist) ‎Tortuous ‎[0 bytes]
80. (hist) ‎Mitral Regurgitation Electrocardiogram ‎[0 bytes]
81. (hist) ‎Quantification of MR ‎[0 bytes]
82. (hist) ‎Mitral Regurgitation Complications and Prognosis ‎[0 bytes]
83. (hist) ‎Unstable angina / NSTEMI bio markers ‎[0 bytes]
84. (hist) ‎UA/NSTEMI unfractionated heparin ‎[0 bytes]
85. (hist) ‎Definitions of coronary stent thrombosis (ST) ‎[0 bytes]
86. (hist) ‎Stent thrombosis: Etiology ‎[0 bytes]
87. (hist) ‎Mitral Stenosis Symptoms ‎[0 bytes]
88. (hist) ‎Mitral Stenosis surgical indications ‎[0 bytes]
89. (hist) ‎Overview ‎[0 bytes]
90. (hist) ‎Overview of Pathophysiology & Etiology ‎[0 bytes]
91. (hist) ‎Right ventricular outflow tract obstruction normal pulmonary valve anatomy ‎[0 bytes]
92. (hist) ‎Right ventricular outflow tract obstruction demographics and epidemiology ‎[0 bytes]
93. (hist) ‎Right ventricular outflow tract obstruction anatomy ‎[0 bytes]
94. (hist) ‎The Most Frequent Causes of Pericarditis ‎[0 bytes]
95. (hist) ‎Right ventricular outflow tract obstruction etiology ‎[0 bytes]
96. (hist) ‎Right ventricular outflow tract obstruction indications for invasive studies ‎[0 bytes]
97. (hist) ‎Myocarditis differential diagnosis of underlying causes ‎[0 bytes]
98. (hist) ‎Pulmonary stenosis etiology and anatomy ‎[0 bytes]
99. (hist) ‎Pulmonic regurgitation antiobiotic prophylaxis ‎[0 bytes]
100. (hist) ‎Ebsteins anomaly of the tricuspid valve epidemiology and demographics ‎[0 bytes]
101. (hist) ‎Aortic dissection pathological findings ‎[0 bytes]
102. (hist) ‎Aortic aneurysm pathological findings ‎[0 bytes]
103. (hist) ‎Tetralogy of fallot ACC/AHA guidelines ‎[0 bytes]
104. (hist) ‎Unstable angina natural history, complications and prognosis ‎[0 bytes]
105. (hist) ‎Unstable angina / NSTEMI ECG ‎[0 bytes]
106. (hist) ‎Unstable angina / NSTEMI chest x-ray ‎[0 bytes]
107. (hist) ‎Unstable angina / NSTEMI echocardiogram ‎[0 bytes]
108. (hist) ‎Unstable angina / NSTEMI angiogram ‎[0 bytes]
109. (hist) ‎Unstable angina/NSTEMI Aspirin therapy ‎[0 bytes]
110. (hist) ‎Unstable angina /NSTEMI Thienopyridines ‎[0 bytes]
111. (hist) ‎UA / NSTEMI: GPIIb/IIIa inhibitor ‎[0 bytes]
112. (hist) ‎Tricuspid atresia ACC/AHA guidelines ‎[0 bytes]
113. (hist) ‎Pericardial effusion CT and MRI ‎[0 bytes]
114. (hist) ‎Chronic stable angina revascularization with PCI and CABG in asymptomatic patients ‎[0 bytes]
115. (hist) ‎Eisenmenger’s syndrome anatomy ‎[0 bytes]
116. (hist) ‎Aortic stenosis surgery devices ‎[0 bytes]
117. (hist) ‎Aortic stenosis surgery aortic valvuloplasty ‎[0 bytes]
118. (hist) ‎ACC AHA recommendations for surgery in adults with previous repair of tetralogy of fallot ‎[0 bytes]
119. (hist) ‎Aortic stenosis surgery (patient information) ‎[0 bytes]
120. (hist) ‎Mitral stenosis surgery external links ‎[0 bytes]
121. (hist) ‎Classification ‎[0 bytes]
122. (hist) ‎Tachypnea treatment ‎[0 bytes]
123. (hist) ‎Hypersensitivity pneumonitis diagnosis overview ‎[0 bytes]
124. (hist) ‎Hypersensitivity pneumonitis treatment ‎[0 bytes]
125. (hist) ‎Allagile syndrome physical examination ‎[0 bytes]
126. (hist) ‎Mitral regurgitation acute ‎[0 bytes]
127. (hist) ‎Mitral regurgitation symptoms ‎[0 bytes]
128. (hist) ‎Mitral regurgitation chest x ray ‎[0 bytes]
129. (hist) ‎Ventricular aneurysmectomy ‎[0 bytes]
130. (hist) ‎Thromboreductive Strategies ‎[0 bytes]
131. (hist) ‎Coronary artery bypass surgery anesthetic consideration ‎[0 bytes]
132. (hist) ‎Hypokalemia laboratory tests ‎[0 bytes]
133. (hist) ‎Hypernatremia treatment ‎[0 bytes]
134. (hist) ‎Coronary artery bypass surgery in renal dysfunction ‎[0 bytes]
135. (hist) ‎Coronary artery bypass surgery management of perioperative dysrhythmias ‎[0 bytes]
136. (hist) ‎Coronary artery bypass surgery perioperative bleeding/transfusion ‎[0 bytes]
137. (hist) ‎Acinic cell carcinoma treatment ‎[0 bytes]
138. (hist) ‎Congenital adrenal hyperplasia pathophysiology ‎[0 bytes]
139. (hist) ‎Congenital adrenal hyperplasia epidemiology and demographics ‎[0 bytes]
140. (hist) ‎Endometrial cancer electrocardiogram ‎[0 bytes]
141. (hist) ‎Endometrial cancer echocardiography or ultrasound ‎[0 bytes]
142. (hist) ‎Carcinoma of the penis electrocardiogram ‎[0 bytes]
143. (hist) ‎Endometrial hyperplasia future or investigational therapies ‎[0 bytes]
144. (hist) ‎Non-Hodgkin lymphoma treatment ‎[0 bytes]
145. (hist) ‎Pheochromocytoma chest x ray ‎[0 bytes]
146. (hist) ‎Pheochromocytoma dietary management ‎[0 bytes]
147. (hist) ‎Pituitary adenoma screening ‎[0 bytes]
148. (hist) ‎Pituitary adenoma electrocardiogram ‎[0 bytes]
149. (hist) ‎Pituitary adenoma chest x ray ‎[0 bytes]
150. (hist) ‎Pituitary adenoma echocardiography or ultrasound ‎[0 bytes]
151. (hist) ‎Peutz-Jeghers syndrome electrocardiogram ‎[0 bytes]
152. (hist) ‎Primary central nervous system lymphoma electrocardiogram ‎[0 bytes]
153. (hist) ‎Primary central nervous system lymphoma echocardiography or ultrasound ‎[0 bytes]
154. (hist) ‎Prolactinoma electrocardiogram ‎[0 bytes]
155. (hist) ‎Prostate cancer electrocardiogram ‎[0 bytes]
156. (hist) ‎Hyperplasia electrocardiogram ‎[0 bytes]
157. (hist) ‎Hyperplasia chest x ray ‎[0 bytes]
158. (hist) ‎Cervical dysplasia electrocardiogram ‎[0 bytes]
159. (hist) ‎Cervical dysplasia chest x ray ‎[0 bytes]
160. (hist) ‎Cervical dysplasia CT ‎[0 bytes]
161. (hist) ‎Cervical dysplasia MRI ‎[0 bytes]
162. (hist) ‎Cervical dysplasia other imaging findings ‎[0 bytes]
163. (hist) ‎Leukemia secondary prevention ‎[0 bytes]
164. (hist) ‎Renal cell carcinoma dietary management ‎[0 bytes]
165. (hist) ‎Malignant rhabdoid tumour screening ‎[0 bytes]
166. (hist) ‎Malignant rhabdoid tumour electrocardiogram ‎[0 bytes]
167. (hist) ‎Malignant rhabdoid tumour chest x ray ‎[0 bytes]
168. (hist) ‎Mammary ductal carcinoma electrocardiogram ‎[0 bytes]
169. (hist) ‎Mediastinal germ cell tumor electrocardiogram ‎[0 bytes]
170. (hist) ‎Medulloblastoma electrocardiogram ‎[0 bytes]
171. (hist) ‎Medulloblastoma primary prevention ‎[0 bytes]
172. (hist) ‎Melanocytic nevus electrocardiogram ‎[0 bytes]
173. (hist) ‎Melanocytic nevus chest x ray ‎[0 bytes]
174. (hist) ‎Melanocytic nevus CT ‎[0 bytes]
175. (hist) ‎Melanocytic nevus echocardiography or ultrasound ‎[0 bytes]
176. (hist) ‎Mesothelioma echocardiography or ultrasound ‎[0 bytes]
177. (hist) ‎Mucinous cystadenocarcinoma screening ‎[0 bytes]
178. (hist) ‎Mucoepidermoid carcinoma screening ‎[0 bytes]
179. (hist) ‎Mucoepidermoid carcinoma electrocardiogram ‎[0 bytes]
180. (hist) ‎Mucoepidermoid carcinoma chest x ray ‎[0 bytes]
181. (hist) ‎Myelofibrosis chest x ray ‎[0 bytes]
182. (hist) ‎Mammary adenosis electrocardiogram ‎[0 bytes]
183. (hist) ‎Mammary adenosis MRI ‎[0 bytes]
184. (hist) ‎Mast cell sarcoma screening ‎[0 bytes]
185. (hist) ‎Mast cell sarcoma electrocardiogram ‎[0 bytes]
186. (hist) ‎Mast cell sarcoma chest x ray ‎[0 bytes]
187. (hist) ‎Mast cell sarcoma primary prevention ‎[0 bytes]
188. (hist) ‎MALT lymphoma electrocardiogram ‎[0 bytes]
189. (hist) ‎MALT lymphoma chest x ray ‎[0 bytes]
190. (hist) ‎Mastocytosis primary prevention ‎[0 bytes]
191. (hist) ‎Meigs syndrome staging ‎[0 bytes]
192. (hist) ‎Meigs syndrome electrocardiogram ‎[0 bytes]
193. (hist) ‎Morton's neuroma classification ‎[0 bytes]
194. (hist) ‎Morton's neuroma screening ‎[0 bytes]
195. (hist) ‎Morton's neuroma staging ‎[0 bytes]
196. (hist) ‎Morton's neuroma electrocardiogram ‎[0 bytes]
197. (hist) ‎Morton's neuroma chest x ray ‎[0 bytes]
198. (hist) ‎Multiple endocrine neoplasia electrocardiogram ‎[0 bytes]
199. (hist) ‎Multiple endocrine neoplasia chest x ray ‎[0 bytes]
200. (hist) ‎Multiple endocrine neoplasia screening ‎[0 bytes]
201. (hist) ‎Malignant fibrous histiocytoma screening ‎[0 bytes]
202. (hist) ‎Malignant fibrous histiocytoma electrocardiogram ‎[0 bytes]
203. (hist) ‎Malignant fibrous histiocytoma chest x ray ‎[0 bytes]
204. (hist) ‎Malignant fibrous histiocytoma echocardiography or ultrasound ‎[0 bytes]
205. (hist) ‎Malignant peripheral nerve sheath tumor electrocardiogram ‎[0 bytes]
206. (hist) ‎Malignant peripheral nerve sheath tumor chest x ray ‎[0 bytes]
207. (hist) ‎Malignant peripheral nerve sheath tumor echocardiography or ultrasound ‎[0 bytes]
208. (hist) ‎Merkel cell cancer electrocardiogram ‎[0 bytes]
209. (hist) ‎Merkel cell cancer chest x ray ‎[0 bytes]
210. (hist) ‎Merkel cell cancer MRI ‎[0 bytes]
211. (hist) ‎Merkel cell cancer echocardiography or ultrasound ‎[0 bytes]
212. (hist) ‎Monocytic leukemia screening ‎[0 bytes]
213. (hist) ‎Monocytic leukemia electrocardiogram ‎[0 bytes]
214. (hist) ‎Anthrax other imaging findings ‎[0 bytes]
215. (hist) ‎Anthrax secondary prevention ‎[0 bytes]
216. (hist) ‎Aspergillosis laboratory tests ‎[0 bytes]
217. (hist) ‎Aspergillosis case studies ‎[0 bytes]
218. (hist) ‎Restenosis history and symptoms ‎[0 bytes]
219. (hist) ‎Paraganglioma chest x ray ‎[0 bytes]
220. (hist) ‎Leiomyosarcoma echocardiography or ultrasound ‎[0 bytes]
221. (hist) ‎Leiomyosarcoma primary prevention ‎[0 bytes]
222. (hist) ‎Confusion differential diagnosis ‎[0 bytes]
223. (hist) ‎Septic arthritis chest x ray ‎[0 bytes]
224. (hist) ‎Paratyphoid fever screening ‎[0 bytes]
225. (hist) ‎Head lice epidemiology and demographics ‎[0 bytes]
226. (hist) ‎Head lice risk factors ‎[0 bytes]
227. (hist) ‎Head lice natural history ‎[0 bytes]
228. (hist) ‎Head lice other diagnostic studies ‎[0 bytes]
229. (hist) ‎Hepatitis A other diagnostic studies ‎[0 bytes]
230. (hist) ‎Rat-bite fever laboratory tests ‎[0 bytes]
231. (hist) ‎Rat-bite fever natural history ‎[0 bytes]
232. (hist) ‎Relapsing fever laboratory tests ‎[0 bytes]
233. (hist) ‎Legionellosis laboratory tests ‎[0 bytes]
234. (hist) ‎Meningitis laboratory tests ‎[0 bytes]
235. (hist) ‎Meningococcemia laboratory tests ‎[0 bytes]
236. (hist) ‎Hepatitis C other imaging findings ‎[0 bytes]
237. (hist) ‎Mumps laboratory tests ‎[0 bytes]
238. (hist) ‎Hepatitis D primary prevention ‎[0 bytes]
239. (hist) ‎Bubonic plague media ‎[0 bytes]
240. (hist) ‎Bubonic plague chest x ray ‎[0 bytes]
241. (hist) ‎Mumps imaging findings ‎[0 bytes]
242. (hist) ‎Congestive heart failure invasive monitoring ‎[0 bytes]
243. (hist) ‎Ebola case studies ‎[0 bytes]
244. (hist) ‎Ebola secondary prevention ‎[0 bytes]
245. (hist) ‎Acoustic neuroma staging ‎[0 bytes]
246. (hist) ‎Ischemic colitis endoscopy ‎[0 bytes]
247. (hist) ‎Natural history template ‎[0 bytes]
248. (hist) ‎Symptoms template ‎[0 bytes]
249. (hist) ‎Wolff-Parkinson-White syndrome EP studies ‎[0 bytes]
250. (hist) ‎Pain diagnosis ‎[0 bytes]
251. (hist) ‎Eye pain treatment ‎[0 bytes]
252. (hist) ‎Eye pain physical exam ‎[0 bytes]
253. (hist) ‎Lysergic Acid Diethylamide ‎[0 bytes]
254. (hist) ‎Cresylic acid ‎[0 bytes]
255. (hist) ‎Peters anomaly ‎[0 bytes]
256. (hist) ‎Amnesia symptoms ‎[0 bytes]
257. (hist) ‎Optic disc vasculitis ‎[0 bytes]
258. (hist) ‎Gullian-Barre syndrome ‎[0 bytes]
259. (hist) ‎Otalgia electrocardiogram ‎[0 bytes]
260. (hist) ‎Otalgia chest x ray ‎[0 bytes]
261. (hist) ‎EncephalopathyCT ‎[0 bytes]
262. (hist) ‎Lymphadenopathy natural history ‎[0 bytes]
263. (hist) ‎Cephaloskeletal dysplasia ‎[0 bytes]
264. (hist) ‎Taybi-Linder syndrome ‎[0 bytes]
265. (hist) ‎Rosai-Dorfman ‎[0 bytes]
266. (hist) ‎HDL deficiency ‎[0 bytes]
267. (hist) ‎Apo A-I deficiency ‎[0 bytes]
268. (hist) ‎Charmaine's disease ‎[0 bytes]
269. (hist) ‎Mycobacterium chelonei ‎[0 bytes]
270. (hist) ‎Anaplasma phagocytophilu ‎[0 bytes]
271. (hist) ‎Mental retardation; large head, imperforate anus; congenital hypotonia, and partial agenesis of the corpus callosum ‎[0 bytes]
272. (hist) ‎Opiod poisoning ‎[0 bytes]
273. (hist) ‎Colorectal cancer follwo up ‎[0 bytes]
274. (hist) ‎Drug allergy erythema multiforme ‎[0 bytes]
275. (hist) ‎Drug allergy toxic epidermal necrolysis ‎[0 bytes]
276. (hist) ‎Drug allergy stevens johnson syndrome ‎[0 bytes]
277. (hist) ‎Methicillin resistant staphylococcus aureus echocardiography or ultrasound ‎[0 bytes]
278. (hist) ‎Larger breasts ‎[0 bytes]
279. (hist) ‎Lesch-Nyhan syndrome echocardiography or ultrasound ‎[0 bytes]
280. (hist) ‎Paget's disease, type 4 ‎[0 bytes]
281. (hist) ‎Infection in the gallbladder ‎[0 bytes]
282. (hist) ‎Mitral valve prolapse primary prevention ‎[0 bytes]
283. (hist) ‎Arthrogryposis historical perspective ‎[0 bytes]
284. (hist) ‎ST elevation myocardial infarction MRI ‎[0 bytes]
285. (hist) ‎ST elevation myocardial infarction echocardiography or ultrasound ‎[0 bytes]
286. (hist) ‎Gout causes ‎[0 bytes]
287. (hist) ‎Arthrogryposis cost-effectiveness of therapy ‎[0 bytes]
288. (hist) ‎Gaucher's disease laboratory tests ‎[0 bytes]
289. (hist) ‎Myalgia (patient information) ‎[0 bytes]
290. (hist) ‎Angioedema CT ‎[0 bytes]
291. (hist) ‎Angioedema ultrasound ‎[0 bytes]
292. (hist) ‎Angioedema surgery ‎[0 bytes]
293. (hist) ‎Angioedema MRI ‎[0 bytes]
294. (hist) ‎Ascites echocardiography or ultrasound ‎[0 bytes]
295. (hist) ‎Anasarca (patient information) ‎[0 bytes]
296. (hist) ‎Back pain chest x ray ‎[0 bytes]
297. (hist) ‎Acute renal failure diagnostic criteria ‎[0 bytes]
298. (hist) ‎Thyroid cancer screening ‎[0 bytes]
299. (hist) ‎Polycystic ovary syndrome echocardiography or ultrasound ‎[0 bytes]
300. (hist) ‎Acne vulgaris further reading ‎[0 bytes]
301. (hist) ‎Amoebiasis other imaging findings ‎[0 bytes]
302. (hist) ‎Mitral valve prolapse secondary prevention ‎[0 bytes]
303. (hist) ‎Tachycardia CT ‎[0 bytes]
304. (hist) ‎Thromboembolism echocardiography other imaging findings ‎[0 bytes]
305. (hist) ‎Abdominal bruit echocardiography or ultrasound ‎[0 bytes]
306. (hist) ‎Cleft lip and palate differential diagnosis ‎[0 bytes]
307. (hist) ‎Chronic pancreatitis electrocardiogram ‎[0 bytes]
308. (hist) ‎Glomus tumor ultrasound ‎[0 bytes]
309. (hist) ‎Chemical pneumonitis diagnostic criteria ‎[0 bytes]
310. (hist) ‎Supraventricular tachycardia primary prevention ‎[0 bytes]
311. (hist) ‎Supraventricular tachycardia MRI ‎[0 bytes]
312. (hist) ‎Transitional cell carcinoma electrocardiogram ‎[0 bytes]
313. (hist) ‎Rhabdomyoma other imaging findings ‎[0 bytes]
314. (hist) ‎Eye neoplasm natural history, complications and prognosis ‎[0 bytes]
315. (hist) ‎Eye neoplasm differential diagnosis ‎[0 bytes]
316. (hist) ‎Eye neoplasm pathophysiology ‎[0 bytes]
317. (hist) ‎Eye neoplasm risk factors ‎[0 bytes]
318. (hist) ‎Pulseless electrical activity other diagnostic studies ‎[0 bytes]
319. (hist) ‎Mucinous cystadenocarcinoma chest x ray ‎[0 bytes]
320. (hist) ‎Thymoma primary prevention ‎[0 bytes]
321. (hist) ‎Thymoma secondary prevention ‎[0 bytes]
322. (hist) ‎Dysplastic nevus historical perspective ‎[0 bytes]
323. (hist) ‎Xerosis laboratory findings ‎[0 bytes]
324. (hist) ‎Lipoid congenital adrenal hyperplasia screening ‎[0 bytes]
325. (hist) ‎Thyroid adenoma biopsy ‎[0 bytes]
326. (hist) ‎Hypomagnesemia surgery ‎[0 bytes]
327. (hist) ‎Compensation Issues ‎[0 bytes]
328. (hist) ‎Granulomatosis with polyangiitis diagnostic criteria ‎[0 bytes]
329. (hist) ‎Coccidioidomycosis electrocardiogram ‎[0 bytes]
330. (hist) ‎Coccidioidomycosis echocardiography or ultrasound ‎[0 bytes]
331. (hist) ‎Lower respiratory tract infection (patient information) ‎[0 bytes]
332. (hist) ‎Interstitial nephritis other imaging findings ‎[0 bytes]
333. (hist) ‎Thoracic aortic disease (patient information) ‎[0 bytes]
334. (hist) ‎Thoracic aortic disease overview ‎[0 bytes]
335. (hist) ‎Thoracic aortic disease historical perspective ‎[0 bytes]
336. (hist) ‎Thoracic aortic disease classification ‎[0 bytes]
337. (hist) ‎Thoracic aortic disease pathophysiology ‎[0 bytes]
338. (hist) ‎Thoracic aortic disease causes ‎[0 bytes]
339. (hist) ‎Thoracic aortic disease differential diagnosis ‎[0 bytes]
340. (hist) ‎Thoracic aortic disease epidemiology and demographics ‎[0 bytes]
341. (hist) ‎Thoracic aortic disease risk factors ‎[0 bytes]
342. (hist) ‎Thoracic aortic disease screening ‎[0 bytes]
343. (hist) ‎Thoracic aortic disease natural history, complications and prognosis ‎[0 bytes]
344. (hist) ‎Thoracic aortic disease history and symptoms ‎[0 bytes]
345. (hist) ‎Thoracic aortic disease physical examination ‎[0 bytes]
346. (hist) ‎Thoracic aortic disease laboratory findings ‎[0 bytes]
347. (hist) ‎Thoracic aortic disease electrocardiogram ‎[0 bytes]
348. (hist) ‎Thoracic aortic disease chest x ray ‎[0 bytes]
349. (hist) ‎Thoracic aortic disease CT ‎[0 bytes]
350. (hist) ‎Thoracic aortic disease MRI ‎[0 bytes]
351. (hist) ‎Thoracic aortic disease echocardiography or ultrasound ‎[0 bytes]
352. (hist) ‎Thoracic aortic disease other imaging findings ‎[0 bytes]
353. (hist) ‎Thoracic aortic disease other diagnostic studies ‎[0 bytes]
354. (hist) ‎Thoracic aortic disease medical therapy ‎[0 bytes]
355. (hist) ‎Thoracic aortic disease surgery ‎[0 bytes]
356. (hist) ‎Thoracic aortic disease primary prevention ‎[0 bytes]
357. (hist) ‎Thoracic aortic disease secondary prevention ‎[0 bytes]
358. (hist) ‎Thoracic aortic disease cost-effectiveness of therapy ‎[0 bytes]
359. (hist) ‎Thoracic aortic disease future or investigational therapies ‎[0 bytes]
360. (hist) ‎Thoracic aortic disease case study one ‎[0 bytes]
361. (hist) ‎Aortic coarctation ACC/AHA Guidelines for clinicical evaluation ‎[0 bytes]
362. (hist) ‎Coronary artery bypass surgery intraoperative use of trans-esophageal echocardiography(TEE) ‎[0 bytes]
363. (hist) ‎Zygomycosis diagnostic criteria ‎[0 bytes]
364. (hist) ‎Ebsteins anomaly of the tricuspid valve anatomy ‎[0 bytes]
365. (hist) ‎Management of Cardiac Arrest Recommendations ‎[0 bytes]
366. (hist) ‎Thoracic aortic disease management during pregnancy ‎[0 bytes]
367. (hist) ‎Percutaneous coronary Intervention heart team approach to revascularization decisions ‎[0 bytes]
368. (hist) ‎Polio causes ‎[0 bytes]
369. (hist) ‎Miliary tuberculosis prevention ‎[0 bytes]
370. (hist) ‎Mitral stenosis general approach to mitral stenosis ‎[0 bytes]
371. (hist) ‎EKG Examples of atrial flutter ‎[0 bytes]
372. (hist) ‎Right ventricular myocardial infarction ekg examples ‎[0 bytes]
373. (hist) ‎Percutaneous Coronary Intervention (PCI) PCI in patients with asymptomatic ischemia or CCS class I or II angina ‎[0 bytes]
374. (hist) ‎Percutaneous Coronary Intervention (PCI) PCI in patients with CCS class III angina ‎[0 bytes]
375. (hist) ‎Percutaneous coronary intervention : basic principles and guidelines ‎[0 bytes]
376. (hist) ‎Neurosyphilis prevention ‎[0 bytes]
377. (hist) ‎Percutaneous Coronary Intervention (PCI) heart team approach to revascularization decisions ‎[0 bytes]
378. (hist) ‎Percutaneous Coronary Intervention (PCI) revascularization to improve symptoms ‎[0 bytes]
379. (hist) ‎Percutaneous Coronary Intervention (PCI) statin treatment ‎[0 bytes]
380. (hist) ‎Percutaneous Coronary Intervention (PCI) bleeding risk ‎[0 bytes]
381. (hist) ‎Percutaneous Coronary Intervention (PCI) role of onsite surgical backup ‎[0 bytes]
382. (hist) ‎Percutaneous Coronary Intervention (PCI) vascular access ‎[0 bytes]
383. (hist) ‎Percutaneous Coronary Intervention (PCI) asymptomatic ischemia or CCS class I or II angina ‎[0 bytes]
384. (hist) ‎Percutaneous Coronary Intervention (PCI) CCS class III angina ‎[0 bytes]
385. (hist) ‎Percutaneous coronary intervention coronary stents ‎[0 bytes]
386. (hist) ‎Hymenolepis infection prevention ‎[0 bytes]
387. (hist) ‎ST elevation myocardial infarction ekg examples ‎[0 bytes]
388. (hist) ‎Amyloidosis echocardiogram ‎[0 bytes]
389. (hist) ‎Ankylosing spondylitis chest x ray ‎[0 bytes]
390. (hist) ‎Thoracic aortic aneurysm in pregnancy ‎[0 bytes]
391. (hist) ‎Thoracic aortic disease imaging ‎[0 bytes]
392. (hist) ‎Behcet's disease chest x ray ‎[0 bytes]
393. (hist) ‎Annuloplasty ‎[0 bytes]
394. (hist) ‎Complex regional pain syndrome criteria ‎[0 bytes]
395. (hist) ‎Beta adrenergic–blocking drug ‎[0 bytes]
396. (hist) ‎Rheumatoid arthritis case 1 ‎[0 bytes]
397. (hist) ‎Septic arthritis laboratory tests ‎[0 bytes]
398. (hist) ‎Iliotibial band syndrome laboratory findings ‎[0 bytes]
399. (hist) ‎Brodie abscess classification ‎[0 bytes]
400. (hist) ‎Nonpathogenic intestinal amebae infection historical perspective ‎[0 bytes]
401. (hist) ‎Nonpathogenic intestinal amebae infection classification ‎[0 bytes]
402. (hist) ‎Southern tick-associated rash illness classification ‎[0 bytes]
403. (hist) ‎Lymphogranuloma venereum laboratory tests ‎[0 bytes]
404. (hist) ‎Lymphogranuloma venereum natural history ‎[0 bytes]
405. (hist) ‎Liver abscess classification ‎[0 bytes]
406. (hist) ‎Liver abscess overview ‎[0 bytes]
407. (hist) ‎Salmonellosis other diagnostic studies ‎[0 bytes]
408. (hist) ‎Myonecrosis (patient information) ‎[0 bytes]
409. (hist) ‎Pott's disease prevention ‎[0 bytes]
410. (hist) ‎Pott's disease imaging findings ‎[0 bytes]
411. (hist) ‎Kaposi's sarcoma laboratory tests ‎[0 bytes]
412. (hist) ‎Primary amoebic meningoencephalitis prevention ‎[0 bytes]
413. (hist) ‎Primary amoebic meningoencephalitis imaging findings ‎[0 bytes]
414. (hist) ‎Buruli ulcer other imaging findings ‎[0 bytes]
415. (hist) ‎Chlamydia infection MRI ‎[0 bytes]
416. (hist) ‎Phlegmon echocardiography or ultrasound ‎[0 bytes]
417. (hist) ‎Trench mouth chest x ray ‎[0 bytes]
418. (hist) ‎Templae:Corneal ulcer (patient information) ‎[0 bytes]
419. (hist) ‎Cytomegalic inclusion body disease surgery ‎[0 bytes]
420. (hist) ‎Isporiasis (patient information) ‎[0 bytes]
421. (hist) ‎Zygomycosis chest x ray ‎[0 bytes]
422. (hist) ‎Nonpathogenic intestinal amebae infection other diagnostic studies ‎[0 bytes]
423. (hist) ‎Malaria other imaging findings ‎[0 bytes]
424. (hist) ‎Leprosy characteristics ‎[0 bytes]
425. (hist) ‎Leprosy natural history ‎[0 bytes]
426. (hist) ‎Unstable angina pathophysiology & etiology ‎[0 bytes]
427. (hist) ‎Non ST elevation myocardial infarction pathophysiology & etiology ‎[0 bytes]
428. (hist) ‎Angioplasty (patient information) ‎[0 bytes]
429. (hist) ‎Aortic dissection echocardiography or ultrasound ‎[0 bytes]
430. (hist) ‎Aortic dissection surgical therapy ‎[0 bytes]
431. (hist) ‎Aortic dissection lifestyle ‎[0 bytes]
432. (hist) ‎Aortic dissection pregnancy ‎[0 bytes]
433. (hist) ‎Gallbladder volvulus prevention ‎[0 bytes]
434. (hist) ‎Pancreatitis chest x ray ‎[0 bytes]
435. (hist) ‎Motor vehicle accident pathophysiology ‎[0 bytes]
436. (hist) ‎Acute renal failure echocardiography or ultrasound ‎[0 bytes]
437. (hist) ‎Asthma laboratory tests ‎[0 bytes]
438. (hist) ‎Asthma MRI and nuclear imaging ‎[0 bytes]
439. (hist) ‎Low back pain (patient information) ‎[0 bytes]
440. (hist) ‎Low back pain-chronic (patient information) ‎[0 bytes]
441. (hist) ‎Low back pain-acute (patient information) ‎[0 bytes]
442. (hist) ‎Lymphadenopathy chest x ray ‎[0 bytes]
443. (hist) ‎Lymphadenopathy classification scheme ‎[0 bytes]
444. (hist) ‎Nail changes screening ‎[0 bytes]
445. (hist) ‎Sandbox/01 ‎[0 bytes]
446. (hist) ‎Pain psychotherapy ‎[0 bytes]
447. (hist) ‎Neonatal lupus erythrematosus ‎[0 bytes]
448. (hist) ‎Neonatal lupus erythrematosus overview ‎[0 bytes]
449. (hist) ‎Neonatal lupus erythrematosus medical therapy ‎[0 bytes]
450. (hist) ‎WBR0134 ‎[0 bytes]
451. (hist) ‎WBR sandbox ‎[0 bytes]
452. (hist) ‎WBR275 ‎[0 bytes]
453. (hist) ‎WBR847 ‎[0 bytes]
454. (hist) ‎Distributive Shock ‎[0 bytes]
455. (hist) ‎Sandbox/43 ‎[0 bytes]
456. (hist) ‎Sandbox vidit4 ‎[0 bytes]
457. (hist) ‎Sandbox vidit5 ‎[0 bytes]
458. (hist) ‎Sandbox vidit6 ‎[0 bytes]
459. (hist) ‎Biliary tract diseases resident survival guide ‎[0 bytes]
460. (hist) ‎Interferon alfa-2a labels and packages ‎[0 bytes]
461. (hist) ‎Interferon alfa-2a microbiology ‎[0 bytes]
462. (hist) ‎Rifapentine clinical studies ‎[0 bytes]
463. (hist) ‎Ceftaroline compatibility and stability ‎[0 bytes]
464. (hist) ‎Sandbox wikinfect steps ‎[0 bytes]
465. (hist) ‎Thymoma Histopathology ‎[0 bytes]
466. (hist) ‎Nexterone injection adverse reactions ‎[0 bytes]
467. (hist) ‎Nexterone injection drug interactions ‎[0 bytes]
468. (hist) ‎Nexterone injection use in specific populations ‎[0 bytes]
469. (hist) ‎Nexterone injection description ‎[0 bytes]
470. (hist) ‎Nexterone injection clinical pharmacology ‎[0 bytes]
471. (hist) ‎Nexterone injection nonclinical toxicology ‎[0 bytes]
472. (hist) ‎Nexterone injection clinical studies ‎[0 bytes]
473. (hist) ‎Sandbox/00007 ‎[0 bytes]
474. (hist) ‎Sandboxtry ‎[0 bytes]
475. (hist) ‎Ramipril and Hydrochlorothiazide tablet ‎[0 bytes]
476. (hist) ‎Sandbox/00016 ‎[0 bytes]
477. (hist) ‎Medication Identification ‎[0 bytes]
478. (hist) ‎Generalized body aches ‎[0 bytes]
479. (hist) ‎Doxazonin sandbox ‎[0 bytes]
480. (hist) ‎Sandbox cvd/overview ‎[0 bytes]
481. (hist) ‎Sandbox SHEKU ‎[0 bytes]
482. (hist) ‎Opening reading frame ‎[0 bytes]
483. (hist) ‎Portuguese man of war dermatitis ‎[0 bytes]
484. (hist) ‎Sclerofuroderma ‎[0 bytes]
485. (hist) ‎Depersonalization/derealization disorder ‎[0 bytes]
486. (hist) ‎Pseudoaldosteronism ‎[0 bytes]
487. (hist) ‎Gastrointestinal Perforation ‎[0 bytes]
488. (hist) ‎Sandbox g3 ‎[0 bytes]
489. (hist) ‎Sandbox infectiousdiseases ‎[0 bytes]
490. (hist) ‎Furosemide (topical) ‎[0 bytes]
491. (hist) ‎Clostridium botulinum 1 ‎[0 bytes]
492. (hist) ‎Sandbox PD ‎[0 bytes]
493. (hist) ‎Mucocutaneous myxoma ‎[0 bytes]
494. (hist) ‎Lentigo maligna ‎[0 bytes]
495. (hist) ‎Sandbox g58 ‎[0 bytes]
496. (hist) ‎The Red Reflex ‎[0 bytes]
497. (hist) ‎MR perfusion ‎[0 bytes]
498. (hist) ‎Sandbox: therapy ‎[0 bytes]
499. (hist) ‎Endocarditis laboratory studies ‎[0 bytes]
500. (hist) ‎Delusional disorder staging ‎[0 bytes]